Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas
- PMID: 12359763
Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas
Abstract
Chromosomal rearrangements involving the immunoglobulin heavy chain gene (IGH) at 14q32 are observed in approximately 50% of patients with B-cell non-Hodgkin's lymphoma (NHL). The 5' end of the IGH gene is located within 8 kb of the telomeric repeats of 14q. Translocations involving the IGH locus and the telomeric band of a partner chromosome are difficult to identify, because most terminal bands of human chromosomes appear pale by conventional G-banding techniques. To determine whether there are cryptic translocations involving the IGH locus, we used dual-color fluorescence in situ hybridization (FISH) of 5' and 3' IGH genomic clones containing the variable sequences, or the J(H) and the 5' constant regions, respectively. We examined cells from 51 patients with B-cell NHL who had a normal karyotype (3 patients), clonal abnormalities not involving 14q32 (35 patients), or alterations of 14q32 other than recurring translocations, i.e., add(14)(q32) (13 patients). FISH detected 17 IGH translocations in 16 of 51 (31%) cases. Of the 13 cases with add(14)(q32), FISH identified the partner chromosome in 9 cases (69%; 3q27, 6 cases; 2p13, 19p13.3, and 18q21.3, 1 case each). Six of thirty-eight (16%) patients without visible alterations of 14q32 and 2 of 13 (15%) patients with an abnormality of one chromosome 14 had masked (5 patients) or cryptic IGH translocations (3 patients), involving 3q27 (3 patients), 5p15.3 (2 patients), 19p13.3 (3 patients), or 14q32 (1 patient; 1 patient had two rearrangements). We identified two novel, recurring, cryptic translocations: t(5;14)(p15.3;q32) (2 patients) and t(14;19)(q32;p13.3) (3 patients). In summary, FISH permitted the detection of cryptic or masked IGH rearrangements in approximately 20% of lymphoma cases without visible rearrangements of 14q32 analyzed retrospectively.
Similar articles
-
Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.Anticancer Res. 2005 Sep-Oct;25(5):3179-82. Anticancer Res. 2005. PMID: 16101124
-
Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma.Cytogenet Genome Res. 2007;118(2-4):345-52. doi: 10.1159/000108319. Cytogenet Genome Res. 2007. PMID: 18000389
-
Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma.Cancer Res. 1993 Jun 15;53(12):2732-5. Cancer Res. 1993. PMID: 8504412
-
Splenic small B-cell lymphoma with IGH/BCL3 translocation.Hum Pathol. 2006 Feb;37(2):218-30. doi: 10.1016/j.humpath.2005.09.025. Hum Pathol. 2006. PMID: 16426923 Review.
-
Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.Semin Oncol. 1998 Aug;25(4):447-60. Semin Oncol. 1998. PMID: 9728595 Review.
Cited by
-
A unique cytogenetic abnormality, t(2;7)(p13.1;p21.3), in a Philadelphia-positive chronic myeloid leukemia.Oncol Lett. 2012 Aug;4(2):209-212. doi: 10.3892/ol.2012.720. Epub 2012 May 17. Oncol Lett. 2012. PMID: 22844355 Free PMC article.
-
The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies.Int J Hematol. 2003 May;77(4):315-20. doi: 10.1007/BF02982637. Int J Hematol. 2003. PMID: 12774917 Review.
-
Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.Mol Cancer. 2010 Dec 21;9:318. doi: 10.1186/1476-4598-9-318. Mol Cancer. 2010. PMID: 21176152 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Research Materials